Literature DB >> 11281973

Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET.

Tetsuya Suhara1, Yasuhiko Sudo, Takashi Okauchi, Jun Maeda, Koichi Kawabe, Kazutoshi Suzuki, Yoshiro Okubo, Yoshifumi Nakashima, Hiroshi Ito, Shuji Tanada, Christer Halldin, Lars Farde.   

Abstract

The aim of the present study was to quantify the density and affinity of human extrastriatal dopamine D2 receptors using positron emission tomography (PET). [(11)C]FLB-457, a high-affinity dopamine D2 receptor antagonist with various specific radioactivities (SA) was used. Eight healthy male subjects, age 20-35 yr, participated twice or three times at different SAs (1-279 GBq/ µmol), and serial dynamic scans were performed in the 3D data acquisition mode. The peak of the specific binding was not well defined with high SA due to the flatness of the curves after 60 min but was observed within the PET measurement. In the experiment with low SA, the peak came earlier than that with high SA. Scatchard analysis was performed using the maximal specific binding value (transient equilibrium) and the radioactivity in the cerebellum as free ligand concentration. The highest density was observed in the thalamus (2.3+/-0.6 pmol/ml), followed by the temporal cortex (1.5+/-0.5 pmol/ml), hippocampus (1.4+/-0.5 pmol/ml), parietal cortex (0.9+/-0.4 pmol/ml), frontal cortex (0.8+/-0.2 pmol/ml) and occipital cortex (0.7+/-0.3 pmol/ml). There was no significant difference in K(d) values in these six regions. The present results demonstrate that dopamine D2 receptor densities in the extrastriatal regions were only 2-8% of that in the striatum. Although the density of extrastriatal dopamine D2 receptor was low, significant regional differences were observed in the present study, as reported in postmortem studies.

Entities:  

Year:  1999        PMID: 11281973     DOI: 10.1017/S1461145799001431

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  25 in total

1.  Striatal and extrastriatal dopamine D₂ receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [¹¹C]raclopride and [¹¹C]FLB457.

Authors:  Keisuke Takahata; Hiroshi Ito; Harumasa Takano; Ryosuke Arakawa; Hironobu Fujiwara; Yasuyuki Kimura; Fumitoshi Kodaka; Takeshi Sasaki; Tsuyoshi Nogami; Masayuki Suzuki; Tomohisa Nagashima; Hitoshi Shimada; Motoichiro Kato; Masaru Mimura; Tetsuya Suhara
Journal:  Psychopharmacology (Berl)       Date:  2012-01-12       Impact factor: 4.530

2.  Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.

Authors:  Sarah A Eisenstein; Jon M Koller; Marilyn Piccirillo; Ana Kim; Jo Ann V Antenor-Dorsey; Tom O Videen; Abraham Z Snyder; Morvarid Karimi; Stephen M Moerlein; Kevin J Black; Joel S Perlmutter; Tamara Hershey
Journal:  Synapse       Date:  2012-05-15       Impact factor: 2.562

3.  Dopamine D2 receptor occupancy by perospirone: a positron emission tomography study in patients with schizophrenia and healthy subjects.

Authors:  Ryosuke Arakawa; Hiroshi Ito; Akihiro Takano; Masaki Okumura; Hidehiko Takahashi; Harumasa Takano; Yoshiro Okubo; Tetsuya Suhara
Journal:  Psychopharmacology (Berl)       Date:  2010-03-27       Impact factor: 4.530

4.  Reference region modeling approaches for amphetamine challenge studies with [11C]FLB 457 and PET.

Authors:  Christine M Sandiego; Jean-Dominique Gallezot; Keunpoong Lim; Jim Ropchan; Shu-fei Lin; Hong Gao; Evan D Morris; Kelly P Cosgrove
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-31       Impact factor: 6.200

Review 5.  Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.

Authors:  Victor W Pike
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

6.  Long-term test-retest reliability of striatal and extrastriatal dopamine D2/3 receptor binding: study with [(11)C]raclopride and high-resolution PET.

Authors:  Kati Alakurtti; Jarkko J Johansson; Juho Joutsa; Matti Laine; Lars Bäckman; Lars Nyberg; Juha O Rinne
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-08       Impact factor: 6.200

7.  High long-term test-retest reliability for extrastriatal 11C-raclopride binding in healthy older adults.

Authors:  Nina Karalija; Lars Jonassson; Jarkko Johansson; Goran Papenberg; Alireza Salami; Micael Andersson; Katrine Riklund; Lars Nyberg; Carl-Johan Boraxbekk
Journal:  J Cereb Blood Flow Metab       Date:  2019-09-10       Impact factor: 6.200

8.  Effect of mazindol on extracellular dopamine concentration in human brain measured by PET.

Authors:  Takeshi Sakayori; Amane Tateno; Ryosuke Arakawa; Yumiko Ikeda; Hidenori Suzuki; Yoshiro Okubo
Journal:  Psychopharmacology (Berl)       Date:  2014-01-08       Impact factor: 4.530

9.  Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; Panayotis K Thanos; Jean Logan; David Alexoff; Yu-Shin Ding; Christopher Wong; Yeming Ma; Kith Pradhan
Journal:  Neuroimage       Date:  2008-06-13       Impact factor: 6.556

10.  Extrastriatal dopamine D(2) receptor occupancy in olanzapine-treated patients with schizophrenia.

Authors:  Ryosuke Arakawa; Hiroshi Ito; Masaki Okumura; Akihiro Takano; Hidehiko Takahashi; Harumasa Takano; Yoshiro Okubo; Tetsuya Suhara
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-10-23       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.